ALK-Abello A/S’s 2014 Outlook Positively Impacted By German Price Reform

Published: Jan 02, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): The new German government has decided to partially revoke the AMNOG pricing act introduced in 2010. Amongst other things, the pricing act entailed a mandatory 16% sales rebate for all prescription drugs and a moratorium fixing prices at 2009 levels. According to the new legislation, the rebate will be reduced to 7% with effect from 1 January 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news